Our lawyers are handling AFFF firefighting foam lawsuits around the country. This page provides the most recent news and updates on the AFFF firefighting foam class action lawsuit and our prediction of the settlement amounts plaintiffs with AFFF cancer lawsuits can expect to receive. You will not get more updated news on the AFFF litigation […]
Our lawyers are handling Paragard IUD removal lawsuits in all 50 states. These lawsuits allege the Paragard intrauterine device breaks upon removal because it is made with inflexible plastic and degrades before the device expires. Over 2,500 lawsuits have been lodged against Teva Pharmaceutical and CooperSurgical by women who encountered issues such as breakage during […]
Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading
Uber has been facing a growing number of allegations and civil lawsuits from rideshare passengers alleging that Uber drivers sexually assaulted them. The lawsuits against Uber allege that the company should be held liable for these sexual assaults because it negligently failed to screen its drivers properly. Recently, a growing number of sexual assault lawsuits […]
Our lawyers are investigating Tepezza hearing loss lawsuits in all 50 states. This page examines Tepezza class action lawsuits, discusses when they might settle, and describes possible settlement amounts (or jury payouts). Continue reading
This page is for victims considering filing a Depo Provera lawsuit. Our lawyers provide the latest updates on these claims, explain the litigation process, and predict Depo Provera settlement amounts. A new scientific study has provided stunning evidence that using Depo-Provera can cause brain tumors. Women who used Depo-Provera and subsequently developed a meningioma brain […]
This page explores Suboxone, its associated dental complications, and the subsequent Suboxone tooth decay lawsuits in 2024. Our lawyers are seeking settlement compensation for victims nationwide who have suffered tooth decay, tooth loss, and tooth erosion from Suboxone. What is the Suboxone lawsuit about? The lawsuit is about what Suboxone does to your teeth. The […]
This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest social media class action lawsuit news. The problem that led to social media lawsuits is millions of people – too many of whom are children – are addicted to social media platforms such […]
Our attorneys also provide the latest updates from the Zantac class action lawsuit (including the disastrous news of the class action judge dismissing all of the federal court Zantac lawsuits. This page was updated on November 22, 2024. If you have a Zantac claim that was not filed or registered in the MDL, call 800-553-8082 or […]
Our lawyers are handling baby powder lawsuits in all 50 states. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women. […]
A Missouri federal district court judge has ordered a Medtronic bone graft lawsuit back to state court.
The case stems from an off-label spinal fusion procedure. Plaintiff sued Medtronic and his surgeon claiming that Infuse bone graft was used in a manner that had not been approved by the U.S. Food and Drug Administration and was therefore an unauthorized off-label use.
Here’s an interesting case that I saw looking at settlements and verdicts last night.
Many product liability cases have a medical malpractice component to them. Certainly, in the mass tort world, the da Vinci robotic surgery claims come to mind. In those cases, patients often blame the manufacturer of the robot and the doctor who performed the operation. The question in these cases is whether jurisdiction for the claim is in state court or federal court, assuming the plaintiff prefers state court as we often do.
In Larson v. Abbott Laboratories, a new federal court decision in Baltimore, Maryland, the plaintiff, who was an HIV-positive space engineer, alleged that the prescription drug Humira caused him an infection that left him with permanent brain damage.
So we have real stakes for everyone. A big-selling pharmaceutical drug – with billions of dollars in sales a year – that is on the verge of being the subject of a big-time mass tort and a plaintiff who has a brain injury that could lead to a substantial jury award. So the stakes are high. (The Humira claims are rarely involving HIV patients and infections, to be precise. But the point is a large verdict, and Humira will set off the Pavlovian dogs.)
Da Vinci Recall
Add one more issue to the mounting problems that Intuitive Surgical is facing with its da Vinci Surgical Robot. The FDA has announced that the mechanical arms on some of the da Vinci robots could stall during robotic surgery, resulting in short-term or medically reversible health problems, or even serious injury. The recall affects 1,386 Patient Side Manipulators on da Vinci S, Si and Si-e Surgical Systems.
New research may indicate a bit of good news for the Da Vinci Surgical System. A study published by the Journal of Endourology indicates that surgeons may reduce the risk of a ureteral injury during robotic prostatectomies.
Good news for Da Vinci?
Through proper preoperative evaluations and planning, surgeons may identify patients who may be at high risk for complications. By focusing on the risk factors that predispose patients to complications, measures can be taken before or during surgery to reduce the probability of injury. Risk factors that predispose patients to complications can include:
Problems on the increase
According to the FDA, problems involving the da Vinci Surgical System are increasing prompting new recommendations for surgeons and calling for more robot surgery training. The problems continue to involve serious injury such as burns, tears, bowl perforations and even death.
An independent investment analysis firm issued a report on October 3rd regarding the increased da Vinci complaints, warning investors about the impact these incidents may have on the stock price for Intuitive Surgical, manufacturer of the da Vinci robot. The report involved figures such as the 2,332 da Vinci complaints received in the first eight months of 2013 as compared with the 4,603 complaints received over the past twelve years from 2000 through 2012. Here is what is even more disconcerting: another study suggests that these problems are often unreported. Who knows that the real data would show?
Continue reading
The concerns over the anti-seizure drug Potiga were given new weight by a new black box warning. The problem is concerns of possible vision loss and blue discoloration of the skin that can be permanent. The FDA says that anyone who considers this drug should get an eye examination both before initiating treatment and every six months during the course of the treatment.
Just as importantly, the FDA underscores the limits of this medication by essentially saying that this medication should only be used by those who have not done well with other options. Why? The risks of taking the drug are pretty high. So it makes sense to make sure every other option has been fully explored with your doctor. So this drug has its place, but only in those situations where Protiga’s benefits outweigh the risk. Of course, this is true with every drug, but particularly so when the risks are what they are here.
Continue reading
C.R. Bard has been in the transvaginal mesh cases from the very beginning. I really believe they will try to put together a global settlement that will resolve more than just the cases with pending trial dates. But in the meantime, Bard will do what it has done from the beginning of this litigation: wage war. But facts are stubborn things which brings us back to the same theme: these cases will settle.
Bard is not only fighting the new cases, it is fighting the battles it has already lost. The most recent battle was a verdict against the company for over $1.4 million.
The case was a good test case although it was a case that was actually pretty favorable to the defendant because the injuries were not as serious as they are in some other cases. It is the classic design defect/failure to warn claims against Bard’s Avaulta Plus, a synthetic mesh product designed to treat pelvic organ prolapse. The woman’s lawsuit claimed that that the arms contained in the mesh device, the small pore size used in the mesh, and the use of polypropylene to make the device were design defects. On their failure to warn claim, the plaintiff argued that Bard inadequately warned about the risk and severity of the complications Plaintiff eventually experienced. Plaintiff also argued the obvious: Bard did not adequately warn of the risks. (Does anyone really disagree with this premise? I don’t know how they argue that one.)
Bard sought a new trial after the verdict, arguing the case never should have gone to the jury. Comically, defense counsel actually conceded that many of these issues appropriately went to the jury. But they did a takesey-backsie (is that how you spell it?) on it arguing that there was not enough design defect evidence to go to the jury.
Risperdal lawsuits have have mostly been resolved as of 2024 after a global settlement was reached. We have updated this post in 2024 to talk about the Risperdal settlements and are leaving the rest of this post up for informational purposes. Our lawyers are no longer seeking new claims.
The lawsuits were primarily based on allegations that Risperdal, an antipsychotic medication, led to the development of gynecomastia in boys and young men, a condition characterized by the growth of breast tissue.
Victims and attorneys have been complaining about da Vinci robotic surgery pr0blems and have made their voice heard by filing lawsuits. The financial exposure of these suits is, I’m sure, a concern of Intuitive Systems. But, I think the voices they listen to the most are those on Wall Street.
What is Wall Street saying? There is a concern now that all of these complications with these da Vinci robots are not yet baked into Intuitive System’s stock price which, despite a surge today, has already taken a beating this year.
These robots are not being purchased or bragged about by hospitals as they have been just last year. The company has blamed the drop in sales on the lack of hospital dollars for new technologies.
But so far this year, there have been 4,603 adverse event records that have been posted for da Vinci. Sure, it is a big country. But let’s put this in context. There were 4603 reports about this technology over the last 12 years.
It gets worse. In August, the number of injury or death events rose to 103, which is the triple that of any other month.
Wall Street is a bit slow in figuring all of this out, but now it is asking the same question lawyers have been asking for a few years.
Continue reading
